Eagle Pharmaceuticals, Inc.
US ˙ OTCPK ˙ US2697961082

Introduction

This page provides a comprehensive analysis of the known insider trading history of Krill Steven L.. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Krill Steven L. has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:EGRX / Eagle Pharmaceuticals, Inc. EVP & Chief Scientific Officer 9,000
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Krill Steven L.. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases EGRX / Eagle Pharmaceuticals, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in EGRX / Eagle Pharmaceuticals, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

EGRX / Eagle Pharmaceuticals, Inc. Insider Trades
Insider Sales EGRX / Eagle Pharmaceuticals, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in EGRX / Eagle Pharmaceuticals, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2017-03-23 EGRX Krill Steven L. 7,025 82.0625 7,025 82.0625 576,489 137 46.6200 -248,984 -43.19
2017-03-22 EGRX Krill Steven L. 7,100 80.0903 7,100 80.0903 568,641
2016-12-23 EGRX Krill Steven L. 5,127 78.6069 5,127 78.6069 403,018
2016-12-22 EGRX Krill Steven L. 5,126 76.7794 5,126 76.7794 393,571
2016-12-21 EGRX Krill Steven L. 2,683 77.1747 2,683 77.1747 207,060
2016-12-21 EGRX Krill Steven L. 7,569 77.1747 7,569 77.1747 584,135
2016-12-20 EGRX Krill Steven L. 10,000 76.6876 10,000 76.6876 766,876
2016-12-19 EGRX Krill Steven L. 2,683 75.6066 2,683 75.6066 202,853
2016-12-19 EGRX Krill Steven L. 7,317 75.6066 7,317 75.6066 553,213
2016-12-15 EGRX Krill Steven L. 3,730 74.7896 3,730 74.7896 278,965
2016-12-15 EGRX Krill Steven L. 6,270 74.7896 6,270 74.7896 468,931
2016-12-13 EGRX Krill Steven L. 10,000 73.6163 10,000 73.6163 736,163
2016-11-30 EGRX Krill Steven L. 1,950 80.0000 1,950 80.0000 156,000
2016-11-30 EGRX Krill Steven L. 2,530 80.0000 2,530 80.0000 202,400
2016-11-30 EGRX Krill Steven L. 1,307 80.0000 1,307 80.0000 104,560
2016-11-23 EGRX Krill Steven L. 200 80.0000 200 80.0000 16,000
2015-06-16 EGRX Krill Steven L. 5,850 81.6000 5,850 81.6000 477,360
2015-06-16 EGRX Krill Steven L. 2,730 81.6000 2,730 81.6000 222,768
2015-06-16 EGRX Krill Steven L. 1,400 81.6000 1,400 81.6000 114,240

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

EGRX / Eagle Pharmaceuticals, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Krill Steven L. as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2018-01-09 2018-01-07 4 EGRX EAGLE PHARMACEUTICALS, INC.
Performance Stock Unit
A - Award 9,000 9,000
2018-01-09 2018-01-07 4 EGRX EAGLE PHARMACEUTICALS, INC.
Employee Stock Option (Right to Buy)
A - Award 15,000 15,000
2018-01-09 2018-01-07 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
A - Award 3,000 3,000
2017-03-24 2017-03-23 4 EGRX EAGLE PHARMACEUTICALS, INC.
Employee Stock Option (right to buy)
M - Exercise -5,000 15,000 -25.00
2017-03-24 2017-03-23 4 EGRX EAGLE PHARMACEUTICALS, INC.
Employee Stock Option (right to buy)
M - Exercise -2,025 4,850 -29.45
2017-03-24 2017-03-23 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale -7,025 0 -100.00 82.06 -576,489
2017-03-24 2017-03-23 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5,000 7,025 246.91 12.63 63,150 88,726
2017-03-24 2017-03-23 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,025 2,025 12.67 25,657 25,657
2017-03-24 2017-03-22 4 EGRX EAGLE PHARMACEUTICALS, INC.
Employee Stock Option (right to buy)
M - Exercise -2,077 6,875 -23.20
2017-03-24 2017-03-22 4 EGRX EAGLE PHARMACEUTICALS, INC.
Employee Stock Option (right to buy)
M - Exercise -5,023 457 -91.66
2017-03-24 2017-03-22 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale -7,100 0 -100.00 80.09 -568,641
2017-03-24 2017-03-22 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,077 7,100 41.35 12.67 26,316 89,957
2017-03-24 2017-03-22 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5,023 5,023 4.42 22,202 22,202
2017-01-06 2017-01-04 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 42,000 42,000
2017-01-04 2016-12-23 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -5,127 53,464 -8.75
2017-01-04 2016-12-23 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale -5,127 0 -100.00 78.61 -403,018
2017-01-04 2016-12-23 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5,127 5,127 46.09 236,303 236,303
2017-01-04 2016-12-22 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -5,126 58,591 -8.04
2017-01-04 2016-12-22 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale -5,126 0 -100.00 76.78 -393,571
2017-01-04 2016-12-22 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5,126 5,126 46.09 236,257 236,257
2017-01-04 2016-12-21 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -7,569 63,717 -10.62
2017-01-04 2016-12-21 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -2,683 20,000 -11.83
2017-01-04 2016-12-21 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale -7,569 0 -100.00 77.17 -584,135
2017-01-04 2016-12-21 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 7,569 7,569 46.09 348,855 348,855
2017-01-04 2016-12-21 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale -2,683 0 -100.00 77.17 -207,060
2017-01-04 2016-12-21 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,683 2,683 12.63 33,886 33,886
2017-01-04 2016-12-20 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -10,000 22,683 -30.60
2017-01-04 2016-12-20 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale -10,000 0 -100.00 76.69 -766,876
2017-01-04 2016-12-20 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 10,000 10,000 12.63 126,300 126,300
2017-01-04 2016-12-19 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -7,317 32,683 -18.29
2017-01-04 2016-12-19 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -2,683 8,952 -23.06
2017-01-04 2016-12-19 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale -7,317 0 -100.00 75.61 -553,213
2017-01-04 2016-12-19 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 7,317 7,317 12.63 92,414 92,414
2017-01-04 2016-12-19 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale -2,683 0 -100.00 75.61 -202,853
2017-01-04 2016-12-19 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,683 2,683 12.67 33,994 33,994
2017-01-04 2016-12-15 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -6,270 11,635 -35.02
2017-01-04 2016-12-15 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -3,730 5,480 -40.50
2017-01-04 2016-12-15 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale -6,270 0 -100.00 74.79 -468,931
2017-01-04 2016-12-15 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 6,270 6,270 12.67 79,441 79,441
2017-01-04 2016-12-15 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale -3,730 0 -100.00 74.79 -278,965
2017-01-04 2016-12-15 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 3,730 3,730 4.42 16,487 16,487
2016-12-15 2016-12-13 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -10,000 9,210 -52.06
2016-12-15 2016-12-13 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale -10,000 0 -100.00 73.62 -736,163
2016-12-15 2016-12-13 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 10,000 10,000 4.42 44,200 44,200
2016-12-02 2016-11-30 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -1,307 19,210 -6.37
2016-12-02 2016-11-30 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -2,530 0 -100.00
2016-12-02 2016-11-30 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -1,950 0 -100.00
2016-12-02 2016-11-30 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale -1,307 0 -100.00 80.00 -104,560
2016-12-02 2016-11-30 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 1,307 1,307 4.42 5,777 5,777
2016-12-02 2016-11-30 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale -2,530 0 -100.00 80.00 -202,400
2016-12-02 2016-11-30 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,530 2,530 8.78 22,213 22,213
2016-12-02 2016-11-30 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale -1,950 0 -100.00 80.00 -156,000
2016-12-02 2016-11-30 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 1,950 1,950 8.78 17,121 17,121
2016-12-02 2016-11-23 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -200 2,530 -7.33
2016-12-02 2016-11-23 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale -200 0 -100.00 80.00 -16,000
2016-12-02 2016-11-23 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 200 200 8.78 1,756 1,756
2016-01-05 2016-01-04 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 62,100 62,100
2015-06-18 2015-06-16 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -1,400 20,517 -6.39
2015-06-18 2015-06-16 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -2,730 2,730 -50.00
2015-06-18 2015-06-16 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -5,850 1,950 -75.00
2015-06-18 2015-06-16 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale -1,400 0 -100.00 81.60 -114,240
2015-06-18 2015-06-16 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 1,400 1,400 4.42 6,188 6,188
2015-06-18 2015-06-16 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale -2,730 0 -100.00 81.60 -222,768
2015-06-18 2015-06-16 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,730 2,730 8.78 23,969 23,969
2015-06-18 2015-06-16 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale -5,850 0 -100.00 81.60 -477,360
2015-06-18 2015-06-16 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5,850 5,850 8.78 51,363 51,363
2015-03-17 2015-03-13 4 EGRX EAGLE PHARMACEUTICALS, INC.
Option (right to buy)
A - Award 71,286 71,286
2014-08-27 2014-08-26 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 40,000 40,000
2014-05-02 2014-04-08 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 17,905 17,905
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)